143 ePosters

Sort By Relevance
View
NO POSTER UPLOADED

031 - ONLINE EDUCATION IMPROVED CLINICIAN KNOWLEDGE RELATED TO TARGETING CD47 FOR THE TREATMENT OF HIGHER-RISK MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA (ID 7)

NO POSTER UPLOADED

095 - INCREASED DNA-CELL-CYCLE S-PHASE FRACTION IS RELATED TO INCREASED INCIDENCES OF IMMATURE MYELOID CELLS AND HIGH IPSS-R RISK ASSESSMENT IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (ID 8)

NO POSTER UPLOADED

037 - ANALYSIS OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES USING DNA-SINGLE CELL ANALYSIS (ID 128)

NO POSTER UPLOADED

015 - CLINICO-GENETIC AND PROGNOSTIC ANALYSES OF 716 PATIENTS WITH PRIMARY MDS AND MDS/AML BASED ON THE 2022 INTERNATIONAL CONSENSUS CLASSIFICATION (ID 130)

NO POSTER UPLOADED

097 - HIGH BM PLASMA S100A8/A9 IS ASSOCIATED WITH A PERTURBED MICROENVIRONMENT AND POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROMES (ID 131)

NO POSTER UPLOADED

138 - ALLOGENEIC ADOPTIVE CELLULAR IMMUNOTHERAPY FOR MYELODYSPLASTIC SYNDROME AND ITS EFFECT ON TRISOMY OF CHROMOSOME 8 (ID 132)

NO POSTER UPLOADED

068 - ALTERED DEVELOPMENTAL PATHWAYS OF INNATE LYMPHOID CELLS IN MYELODYSPLASTIC SYNDROMES CORRELATE DISEASE PROGNOSIS AND RESPONSE TO THERAPY (ID 139)

NO POSTER UPLOADED

050 - TP53 ALLELIC STATE DID NOT INFLUENCE THE PROGNOSIS IN MYELODYSPLASTIC SYNDROMES (MDS) WITH 5Q DELETION (ID 142)

NO POSTER UPLOADED

002 - DIAGNOSTIC CHALLENGE BETWEEN WHO AND ICC CLASSIFICATION (ID 144)

NO POSTER UPLOADED

116 - CLINICO-BIOLOGICAL CHARACTERISTICS AND OUTCOME OF 313 CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS INCLUDING 104 FORMERLY REFERRED TO AS OLIGOMONOCYTIC (ID 145)

NO POSTER UPLOADED

125 - LUSPATERCEPT FOR PATIENTS WITH LOWER RISK MDS ADMITTED TO THE HEMATOLOGY DEPARTMENT OF THE COLENTINA CLINICAL HOSPITAL - DATA FROM CLINICAL EXPERIENCE (ID 149)

NO POSTER UPLOADED

053 - EXPLORING IMMUNE ACTIVATION IN MYELOID MALIGNANCIES (ID 151)